Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 119 Results Clear All
The Washington Post—As it explores whether reprogramming our genes can make us young again, this article highlights the Noble Prize winning discovery by Gladstone Investigator Shinya Yamanaka. (Subscription required.)
Gladstone Experts Yamanaka Lab Stem Cells/iPSCs
The San Francisco Experience—In a podcast interview, Gladstone President Deepak Srivastava discusses the mission of Gladstone Institutes, and describes how advances in stem cell biology, genome engineering, and artificial intelligence are making it possible to understand the core of diseases and develop new cures.
Gladstone Experts Srivastava Lab AI CRISPR/Gene Editing Stem Cells/iPSCs
The Medicine Maker—In this Q&A, the head of the California Institute for Regenerative Medicine highlights the game-changing scientific contributions of Gladstone’s Shinya Yamanaka and Jennifer Doudna.
Gladstone Experts CRISPR/Gene Editing Stem Cells/iPSCs
Winner of the 2024 Ogawa-Yamanaka Stem Cell Prize, Rusty Gage made landmark discoveries that fundamentally shifted the field of neuroscience.
Awards Ogawa Stem Cell Prize Profile Stem Cells/iPSCs
Gage has reshaped our understanding of stem cells in the adult brain with landmark discoveries that may contribute to the development of new or better therapies for neurological disorders.
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs
Forbes—The world woke up 17 years ago to an astounding scientific breakthrough: a team of Japanese scientists led by Shinya Yamanaka—now an investigator at Gladstone—had reprogrammed skin cells to resemble an embryonic state. In this interview, Yamanaka shares fascinating insights about the backstory of his work and the doors it is starting to open for patients today.
Gladstone Experts Yamanaka Lab Stem Cells/iPSCs
The Voice of San Francisco—Gladstone President Deepak Srivastava, MD, talks about technologies driving the next wave of medicine, the importance of philanthropy dollars in fueling scientific breakthroughs, and how biotech is still breathing life into San Francisco's Mission Bay neighborhood.
Philanthropy Srivastava Lab Aging AI CRISPR/Gene Editing Stem Cells/iPSCs
Funds from the California Institute for Regenerative Medicine will allow Gladstone to bolster its disease-modeling technologies, add robust CRISPR screening capabilities, and educate young researchers on the latest in stem cell science.
Grants Assay Development and Drug Discovery Core Bioinformatics Core Stem Cell Core CRISPR/Gene Editing Disease Models Organoids Regenerative Medicine Stem Cells/iPSCs
At San Francisco’s Exploratorium, visitors sync their heartbeat with living heart cells; the first-of-its-kind exhibit was created through the museum’s long-running partnership with scientists at Gladstone Institutes.
News Release Stem Cells/iPSCs Conklin Lab Yamanaka Lab Cardiovascular Disease Research (Publication)
Magdalena Zernicka-Goetz, recipient of the 2023 Ogawa-Yamanaka Stem Cell Prize, has created self-assembling embryo-like models that are advancing regenerative medicine
Awards Ogawa Stem Cell Prize Profile Stem Cells/iPSCs
AHA with JAHA Podcast—In a roundtable forum, the American Heart Association’s 2023 Distinguished Scientists describe their contributions to stroke and cardiovascular research. Gladstone President Deepak Srivastava discusses the use of human iPS cells in drug discovery and his hopes for the future of science and medicine, including applications of artificial intelligence.
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Human Genetics Stem Cells/iPSCs
How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine
Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott Lab
UCSF News—Gladstone Senior Investigators Alex Marson and Jennifer Doudna, and President of the UC San Francisco Helen Diller Family Comprehensive Cancer Center Alan Ashworth, will head the newly launched CRISPR Cures for Cancer Initiative, which will fund research at the intersection of genomic technologies and cellular immunotherapies at Gladstone Institutes, UC San Francisco, and the Innovative Genomics Institute at UC Berkeley.
Gladstone Experts Cancer Data Science and Biotechnology Genomic Immunology Doudna Lab Marson Lab CRISPR/Gene Editing Stem Cells/iPSCs
A Q&A with researchers Bruce Conklin and Juan Perez-Bermejo
Research (Publication) Mass Spectrometry Facility Heart Failure Data Science and Biotechnology Conklin Lab Krogan Lab Stem Cells/iPSCs
